Avoro Capital Advisors LLC - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 30 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 2.31 and the average weighting 0.5%.

Quarter-by-quarter ownership
Avoro Capital Advisors LLC ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$9,012,000
-14.9%
1,200,0000.0%0.14%
-2.1%
Q2 2023$10,596,000
+6.1%
1,200,0000.0%0.14%
-2.7%
Q1 2023$9,984,000
-13.3%
1,200,0000.0%0.15%
-14.0%
Q4 2022$11,520,000
+18.5%
1,200,0000.0%0.17%
-4.4%
Q3 2022$9,720,000
+43.4%
1,200,0000.0%0.18%
+34.3%
Q2 2022$6,780,000
+0.9%
1,200,0000.0%0.13%
+8.9%
Q1 2022$6,720,000
+27.3%
1,200,0000.0%0.12%
+36.7%
Q4 2021$5,280,000
-66.4%
1,200,000
-28.1%
0.09%
-63.6%
Q3 2021$15,731,000
+29.2%
1,670,0000.0%0.25%
+16.5%
Q2 2021$12,174,000
+17.4%
1,670,0000.0%0.21%
+18.4%
Q1 2021$10,371,000
-16.6%
1,670,0000.0%0.18%
-16.4%
Q4 2020$12,442,000
+22.9%
1,670,0000.0%0.21%
+48.6%
Q3 2020$10,120,000
-27.4%
1,670,0000.0%0.14%
-47.8%
Q2 2020$13,945,000
+112.3%
1,670,000
+51.0%
0.28%
+24.3%
Q1 2020$6,570,000
-8.3%
1,105,9990.0%0.22%
+5.7%
Q4 2019$7,167,000
+34.7%
1,105,9990.0%0.21%
-5.4%
Q3 2019$5,320,000
+20.3%
1,105,9990.0%0.22%
+45.1%
Q2 2019$4,424,000
-17.5%
1,105,9990.0%0.15%
-34.1%
Q1 2019$5,364,000
-24.0%
1,105,9990.0%0.23%
-45.0%
Q4 2018$7,056,000
-15.9%
1,105,999
+8.1%
0.42%
+9.6%
Q3 2018$8,386,000
-21.6%
1,022,6660.0%0.38%
-6.6%
Q2 2018$10,700,000
+225.8%
1,022,666
+275.1%
0.41%
+162.4%
Q1 2018$3,284,000
+20.5%
272,666
+32.4%
0.16%
-11.3%
Q4 2017$2,726,000
+272.9%
206,000
+209.0%
0.18%
+210.5%
Q3 2017$731,00066,6660.06%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sonic GP LLC 2,407,357$18,079,25117.55%
Solas Capital Management, LLC 1,725,567$12,959,0089.07%
DG Capital Management, LLC 1,143,099$8,584,6734.70%
HARBERT FUND ADVISORS, INC. 466,869$3,506,1862.56%
AIGH Capital Management LLC 373,526$2,805,1801.33%
Southpoint Capital Advisors LP 4,077,214$30,619,8770.68%
APIS CAPITAL ADVISORS, LLC 70,000$525,7000.68%
Worth Venture Partners, LLC 92,636$695,6960.41%
Lion Point Capital, LP 110,000$826,1000.37%
683 Capital Management, LLC 300,000$2,253,0000.18%
View complete list of FENNEC PHARMACEUTICALS INC shareholders